Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Stem Holdings's pretax income for the
three
months ended in Sep. 2023 was $2.22 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was $-5.17 Mil.
Stem Holdings's pretax margin was -18.83%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stem Holdings Pre-Tax Income Related Terms
Stem Holdings Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Stem Holdings's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STMH vs NXEN, VFRM, ENDPQ: Pre-Tax Income Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stem Holdings Pre-Tax Income vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Stem Holdings's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stem Holdings (STMH) has a Pre-Tax Income of $-5.17 Mil as of Sep. 2023. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Stem Holdings and its competitors.
Is Stem Holdings' Pre-Tax Income too high?
Stem Holdings' current Pre-Tax Income is $-5.17 Mil. Overall, Stem Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Stem Holdings' Pre-Tax Income compare to NXEN and VFRM?
Stem Holdings' Pre-Tax Income of $-5.17 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Drug Manufacturers company?
A good Pre-Tax Income depends on the Drug Manufacturers industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Stem Holdings and its competitors. Stem Holdings's current Pre-Tax Income is $-5.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Holdings stock overvalued right now?
Stem Holdings (STMH) has a current Pre-Tax Income of $-5.17 Mil. The current Pre-Tax Income is $-5.17 Mil. Stem Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Stem Holdings (STMH), the current Pre-Tax Income is $-5.17 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
12GF Score
Get the complete analysis for STMH
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STMH has been successfully added to your 
